Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Monivann Ung"'
Autor:
Ivan Pourmir, Reza Elaidi, Zineb Maaradji, Hortense de Saint Basile, Monivann Ung, Benoit Gazeau, Laure Fournier, Bastien Rance, Laure Gibault, Mohammed Ismaili, Elizabeth Fabre
AimsAnti-PD-1/PD-L1 can face the issue of tumor resistance in advanced non-small cell lung cancer (aNSCLC), mostly as primary resistance to the treatment. Still, disease progression (PD) also occurs after prior durable clinical benefit (DCB). Compari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00b83a990a93297887f05a11a9da50fd
https://doi.org/10.1101/2023.03.09.23287023
https://doi.org/10.1101/2023.03.09.23287023
Autor:
Pourmir, Ivan1,2 (AUTHOR) ivan.pourmir@aphp.fr, Elaidi, Reza1 (AUTHOR) zineb.maaradji@aphp.fr, Maaradji, Zineb1 (AUTHOR) mohammed.ismaili@aphp.fr, De Saint Basile, Hortense1 (AUTHOR) rym.ben-dhiab@aphp.fr, Ung, Monivann3 (AUTHOR) monivann.ung@aphp.fr, Ismaili, Mohammed1 (AUTHOR) benoit.gazeau@aphp.fr, Fournier, Laure3 (AUTHOR) laure.fournier@aphp.fr, Rance, Bastien4 (AUTHOR) bastien.rance@aphp.fr, Gibault, Laure5 (AUTHOR) laure.gibault@aphp.fr, Ben Dhiab, Rym1 (AUTHOR) elizabeth.fabre@aphp.fr, Gazeau, Benoit1 (AUTHOR), Fabre, Elizabeth1,2 (AUTHOR)
Publikováno v:
Cancers. Dec2023, Vol. 15 Issue 23, p5587. 16p.
